TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20690416

Group type: EXPERIMENTAL
Intervention: Maxcem (MA) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smartcem (SM) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rely X Unicem Aplicap (UN) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breeze (BR) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biscem (BI) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Set (SE) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil SA luting (CL) with silica coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maxcem (MA) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smartcem (SM) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rely X Unicem Aplicap (UN) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breeze (BR) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biscem (BI) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Set (SE) with tribochemical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil SA luting (CL) with tribochemical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: #600 polishing (control group)
Number of subjects: 0
Study: 17505991

Group type: EXPERIMENTAL
Intervention: Successful eradication of H. pylori
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Size of the index ulcer (<=10 mm versus >10 mm)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Atrophic gastritis versus no atrophy
Number of subjects: 333
Study: 16182353

Group type: EXPERIMENTAL
Intervention: d-Amphetamine (0, 2.5, 5, 10 and 15 mg) alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxazepam (20 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oxazepam (20 mg) + d-Amphetamine (15 mg)
Number of subjects: 6
Study: 12106937

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 4054
Study: 10093841

Group type: EXPERIMENTAL
Intervention: Fast FLAIR imaging
Number of subjects: 47
Study: 7475282

Group type: EXPERIMENTAL
Intervention: Ranitidine treatment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 31
Study: 2278365

Group type: EXPERIMENTAL
Intervention: Etomidate in lipid emulsion (20 mg in 10 ml of Lipofundin MCT 20%)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Etomidate in propylene glycol (35% solution)
Number of subjects: 100
Study: 31553204

Group type: EXPERIMENTAL
Intervention: MgBRS
Number of subjects: 150

Group type: COMPARATOR
Intervention: SES
Number of subjects: 150
Study: 30256569

Group type: EXPERIMENTAL
Intervention: Health behavior modification program
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 66
Study: 26883307

Group type: EXPERIMENTAL
Intervention: Community leader engagement
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Community leader engagement with community days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Community leader engagement with community days and male and female community peer groups
Number of subjects: 45
Study: 24792208

Group type: EXPERIMENTAL
Intervention: Mechanical loading at 50% body weight
Number of subjects: 137
Study: 23096013

Group type: EXPERIMENTAL
Intervention: Soybean oil (SO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-SFA soybean oil (LoSFA-SO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-oleic acid soybean oil (HiOleic-SO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrogenated soybean oil (Hydrog-SO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-ALA soybean oil (LoALA-SO)
Number of subjects: 18
Study: 20170026

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening using the Pap test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CA 125 test for detecting relapse in ovarian cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initiation of therapy for ovarian cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revised staging for cervical, endometrial, and vulvar cancer by FIGO
Number of subjects: 0
Study: 17710561

Group type: EXPERIMENTAL
Intervention: Pharmacist recommendations for drug therapy changes (267 recommendations total)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pharmacist recommendations to add a new antihypertensive medication (46.4%) or increase a dose (33.3%)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Average blood pressure at baseline: 153.1±10.0/84.9±12.0 mmHg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pharmacist recommendations for no change in treatment plan (361 times)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall BP control rates
Number of subjects: 101
Study: 15877552

Group type: EXPERIMENTAL
Intervention: Standardized video vignettes of an elderly patient depicting late-life depression
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: PCP characteristics (location of medical school training)
Number of subjects: 178
Study: 12607119

Group type: EXPERIMENTAL
Intervention: Unilateral varicose vein surgery
Number of subjects: 73

Group type: COMPARATOR
Intervention: Bilateral varicose vein surgery
Number of subjects: 73
Study: 10388959

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.05% gel
Number of subjects: 375

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 375
Study: 8697168

Group type: EXPERIMENTAL
Intervention: VVI pacing
Number of subjects: 20

Group type: COMPARATOR
Intervention: DDD pacing
Number of subjects: 20
Study: 1997933

Group type: EXPERIMENTAL
Intervention: Metoclopramide (3 mg/kg, 15 min i.v.)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Droperidol (1.25 mg slow push)
Number of subjects: 36
Study: 6359995

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30898462

Group type: EXPERIMENTAL
Intervention: PCR-based approach
Number of subjects: 140

Group type: COMPARATOR
Intervention: Physician choice of antibiotic
Number of subjects: 140

Group type: COMPARATOR
Intervention: Prebiopsy cultures
Number of subjects: 140
Study: 29871025

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic treatment
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 27291558

Group type: EXPERIMENTAL
Intervention: Bipolar TURBT (B‐TURBT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Monopolar TURBT (M‐TURBT)
Number of subjects: 130
Study: 25085298

Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser treatment (beam diameter, 0.2 mm; power, 0.7 W)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Visible guiding light (control)
Number of subjects: 16
Study: 22147075

Group type: EXPERIMENTAL
Intervention: Dacomitinib (45 mg) plus Dextromethorphan (DM)
Number of subjects: 14
Study: 18852068

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 107
Study: 17382026

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus EGFR tyrosine kinase inhibitors (gefitinib or erlotinib)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 4000
Study: 15105062

Group type: EXPERIMENTAL
Intervention: Triphasic combined oral contraceptive (COC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group of 49 non-COC-user women
Number of subjects: 29
Study: 12192203

Group type: EXPERIMENTAL
Intervention: Various interventions discussed in literature (specific interventions not detailed in the abstract)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potential future therapies and prophylactic recommendations
Number of subjects: 0
Study: 11579697

Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rock music and noise
Number of subjects: 0
Study: 8130022

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Metolazone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination treatment (Bendrofluazide + Loop diuretic)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Prolonged treatment (Bendrofluazide + Loop diuretic)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination treatment (Bendrofluazide + Metolazone + Loop diuretic)
Number of subjects: 33
Study: 2502921

Group type: EXPERIMENTAL
Intervention: EN‐8715 (8% soluble fiber, 18% Polycose, 7% fructose, 50% fat, 17% protein)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ensure HN (53% simple carbohydrates, 30% fat, 17% protein)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: EN‐8715
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ensure HN
Number of subjects: 10
Study: 29973165

Group type: EXPERIMENTAL
Intervention: Individual Health Management (IHM) lifestyle program, including access to a web-based health portal and participation in training sessions (3 full-day and 10 two-hour sessions in the first 3 months, followed by 4 training sessions and weekly monitoring for 9 months).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with access to the IHM program after a waiting period of at least 6 months.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IHM program includes examinations for burnout symptoms, heart rate variability, laboratory and physical findings, and patient-reported outcomes such as well-being, life satisfaction, severity of mood state, sense of coherence, psycho-vegetative test, cardio-metabolic risk factors, hypertension, and diabetes risk.
Number of subjects: 0
Study: 29211279

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine pre‐procedural rinse
Number of subjects: 54

Group type: COMPARATOR
Intervention: No rinse before dental scaling
Number of subjects: 54
Study: 26630910

Group type: EXPERIMENTAL
Intervention: High-intensity functional exercise program (intensive strengthening and balance exercises in small groups twice a week for 12 weeks)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: High-intensity functional exercise program
Number of subjects: 170

Group type: COMPARATOR
Intervention: Leisure activities (control group)
Number of subjects: 170
Study: 24517948

Group type: EXPERIMENTAL
Intervention: Continuous-infusion elastomeric pump with local anesthetic (LA)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCA)
Number of subjects: 285
Study: 20864217

Group type: EXPERIMENTAL
Intervention: Antimicrobial trilayer gloves (group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-layer gloves (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double-layer gloves (group B)
Number of subjects: 0
Study: 18443351

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Elevated serum TIMP-1
Number of subjects: 522
Study: 16231250

Group type: EXPERIMENTAL
Intervention: Dalbavancin (1000 mg IV on day 1 and 500 mg IV on day 8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linezolid (600 mg IV or orally every 12 hours for 14 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalbavancin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dalbavancin and Linezolid
Number of subjects: 0
Study: 12470424

Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) of activated leukocytes after stimulation with GM-CSF
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) of activated leukocytes after stimulation with IL-2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of HAI of melphalan (50 mg) and activated leukocytes
Number of subjects: 10

Group type: COMPARATOR
Intervention: HAI of melphalan (50 mg) alone
Number of subjects: 10
Study: 10517717

Group type: EXPERIMENTAL
Intervention: One-page, low-literacy educational handout encouraging patients to 'ask your doctor about the pneumonia shot'
Number of subjects: 433

Group type: COMPARATOR
Intervention: One-page, low-literacy educational handout conveying information about nutrition (Control)
Number of subjects: 433
Study: 7864411

Group type: EXPERIMENTAL
Intervention: Enalaprilat (0.06 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 14
Study: 1827641

Group type: EXPERIMENTAL
Intervention: 10,000 lux white light for 40 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400 lux red light (placebo) for 40 minutes
Number of subjects: 10
Study: 6952022

Group type: EXPERIMENTAL
Intervention: Supervised running (n = 48)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sedentary control (n = 33)
Number of subjects: 81
Study: 31549286

Group type: EXPERIMENTAL
Intervention: Neuromonitorisation group (n=30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (n=31)
Number of subjects: 61
Study: 31088436

Group type: EXPERIMENTAL
Intervention: Positive Feedback (PF)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Negative Feedback (NF)
Number of subjects: 110
Study: 28822046

Group type: EXPERIMENTAL
Intervention: Subcutaneous abatacept (125 mg/week)
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Intravenous abatacept (10 mg/kg/month)
Number of subjects: 1456

Group type: COMPARATOR
Intervention: Subcutaneous and Intravenous abatacept
Number of subjects: 1456
Study: 26427563

Group type: EXPERIMENTAL
Intervention: Exercise arm (activity tracker, phone calls, tailored and non-tailored email content)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control arm (emails on women's health topics)
Number of subjects: 80
Study: 22510252

Group type: EXPERIMENTAL
Intervention: OROS hydromorphone ER
Number of subjects: 112

Group type: COMPARATOR
Intervention: Oxycodone CR
Number of subjects: 112
Study: 20947593

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 µg kg⁻¹ (R0.5 group, n=24)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 µg kg⁻¹ (R1.0 group, n=24)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both doses of remifentanil
Number of subjects: 48
Study: 19067065

Group type: EXPERIMENTAL
Intervention: Diltiazem 2 microg/kg/min
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 32
Study: 17636223

Group type: EXPERIMENTAL
Intervention: COMT Val158Met polymorphism
Number of subjects: 972
Study: 15553818

Group type: EXPERIMENTAL
Intervention: Compound Salvia injection (CSI) plus conventional treatment of western medicine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 64
Study: 16206673

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 9624237

Group type: EXPERIMENTAL
Intervention: CHART trial with dedicated local trials staff for administering quality of life questionnaires.
Number of subjects: 0

Group type: COMPARATOR
Intervention: LU12 and LU13 trials without dedicated local trials staff.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All trials (LU12, LU13, CHART) administering Rotterdam Symptom Checklist (RSCL) and Hospital Anxiety and Depression Scale (HADS).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measures implemented to improve compliance and standardisation.
Number of subjects: 0
Study: 7659586

Group type: EXPERIMENTAL
Intervention: Composite Rhythm file method for AF detection
Number of subjects: 20
Study: 2544523

Group type: EXPERIMENTAL
Intervention: Strict diastolic blood pressure (DBP) control (less than or equal to 80 mm Hg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional levels of diastolic blood pressure (90-95 mm Hg)
Number of subjects: 79
Study: 4909450

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 80

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 80
Study: 29546692

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplement of 4000 IU for 3 years
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 28894429

Group type: COMPARATOR
Intervention: Group 1 (completed items on affective and cognitive attitudes)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Group 2 (excluded affective attitudes)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Group 3 (omitted negatively worded affective attitudes)
Number of subjects: 349
Study: 25168752

Group type: EXPERIMENTAL
Intervention: RapidArc (RA)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard sliding window IMRT (swIMRT)
Number of subjects: 157
Study: 24047668

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention program (including nutrition classes, group exercise, and enjoying meals with community members)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 21658262

Group type: EXPERIMENTAL
Intervention: Cameroon Mobile Phone SMS intervention
Number of subjects: 0
Study: 19875974

Group type: EXPERIMENTAL
Intervention: Surgery followed by adjuvant treatment with tegafur-uracil (UFT)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 1269
Study: 16773286

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (prep group)
Number of subjects: 249

Group type: COMPARATOR
Intervention: No mechanical bowel preparation (non-prep group)
Number of subjects: 249
Study: 15296809

Group type: EXPERIMENTAL
Intervention: Dietary Modification (DM) component
Number of subjects: 161856

Group type: EXPERIMENTAL
Intervention: Hormone-Replacement Therapy (HRT) component
Number of subjects: 161856

Group type: EXPERIMENTAL
Intervention: African Americans in DM component
Number of subjects: 161856

Group type: EXPERIMENTAL
Intervention: Hispanics in HRT component
Number of subjects: 161856

Group type: EXPERIMENTAL
Intervention: Overall recruitment strategies
Number of subjects: 161856
Study: 10936836

Group type: EXPERIMENTAL
Intervention: Infiltration anesthesia with 3.6 mL of lidocaine with 1:80,000 epinephrine (L-E)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Ergometer-stress testing at 25 watts (W) for young subjects and at 15 W for older subjects
Number of subjects: 21
Study: 9555218

Group type: EXPERIMENTAL
Intervention: Helioseal F
Number of subjects: 62

Group type: COMPARATOR
Intervention: Delton opaque (unfilled control)
Number of subjects: 62
Study: 8335655

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 2906476

Group type: EXPERIMENTAL
Intervention: olsalazine, 3 g/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: sulphasalazine, 3 g/day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: olsalazine
Number of subjects: 56

Group type: COMPARATOR
Intervention: sulphasalazine
Number of subjects: 56
Study: 31191101

Group type: EXPERIMENTAL
Intervention: 4x5 repetition maximum band-resisted squat jumps
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 12
Study: 28740945

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Exercises once per week (WBVE1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Exercises twice per week (WBVE2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 26836268

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil supplementation for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intake for 8 weeks
Number of subjects: 0
Study: 23397984

Group type: EXPERIMENTAL
Intervention: Brief educational program (six-sessions) for parents
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (parents not given the intervention)
Number of subjects: 103
Study: 21942748

Group type: EXPERIMENTAL
Intervention: Breathing exercise (simplified Buteyko technique) with easy task instructions
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Breathing exercise (simplified Buteyko technique) with difficult task instructions
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 57
Study: 18696039

Group type: COMPARATOR
Intervention: Standard lymphadenectomy (obturator and external nodes)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy (complete pelvic nodes up to the inferior mesenteric artery)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Detection of occult disseminated tumor cells using RT-PCR
Number of subjects: 19
Study: 20090483

Group type: EXPERIMENTAL
Intervention: Tono-Pen XL
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tono-Pen XL and GAT
Number of subjects: 52
Study: 15620953

Group type: EXPERIMENTAL
Intervention: Intrathoracoscopic ultrasound (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Finger palpation (group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Radio-guided technique (group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Finger palpation (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasound technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Radio-guided technique
Number of subjects: 50
Study: 12372097

Group type: EXPERIMENTAL
Intervention: Aloesin treatment (administered four times a day for 15 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Arbutin treatment (administered four times a day for 15 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aloesin and arbutin cotreatment (administered four times a day for 15 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Aloesin treatment (dose-dependent)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 15
Study: 9532967

Group type: EXPERIMENTAL
Intervention: Random interval repetition task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-task random-interval repetition performance
Number of subjects: 0
Study: 8023079

Group type: EXPERIMENTAL
Intervention: Group gymnastics for neck pain (45 min once a week for 10 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44